:::::::OK, now I found the part about her in the ALF section. My opinion (influenced a lot by the recent discussions of BLP and of the insulin matter): I think that we should treat both of them the same way, no matter what we do, because it would be POV to treat the two of them differently. And I would come down on the side of not naming either one of them by name. I don't think it adds anything, in either case, to provide the name, and I think that both instances are of marginal justification to name names, in part per WP:PERP. My suggestion would be, in both cases, just to refer to them as "an employee" of the respective organization.